Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,046.76
-12.7764-0.62%
Number of Gainers:2
Number of Losers:8
Number of Flat:1
PE:- -
High:2,071.43
Open:2,059.35
Low:2,038.48
Close:2,059.53
Volume:16.96M
Turnover:976.12M
Market Cap:226.53B
Float Cap:225.83B

Loading ...

Apple Health app users can order labs from Quest Diagnostics

TIPRANKS
·
14 hours ago

Quest Diagnostics Lab Testing to be Available for Purchase in Apple Health App Later This Year

Reuters
·
14 hours ago

Viatris Price Target Announced at $20.00/Share by Leerink Partners

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Reuters
·
Yesterday

Leerink Starts Viatris at 'outperform' on Improving Growth

Reuters
·
Yesterday

Emergent Biosolutions Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday

Viatris Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Price Target $20

THOMSON REUTERS
·
Yesterday

Viatris initiated with an Outperform at Leerink

TIPRANKS
·
Yesterday

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Yesterday

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Reuters
·
Yesterday

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Yesterday

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS
·
Yesterday

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

TradingKey
·
Yesterday

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS
·
Yesterday

Quest Diagnostics Inc : UBS Raises Target Price to $245 from $232

THOMSON REUTERS
·
Sep 08

Viatris Price Target Raised to $20.00/Share from $15.00 by Argus Research

Dow Jones
·
Sep 08

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026

Reuters
·
Sep 08

Argus Adjusts Price Target on Viatris to $20 From $18, Keeps Buy Rating

MT Newswires Live
·
Sep 08

Tonix Pharmaceuticals Files Form 3 for Chief Commercial Officer Thomas Englese

Reuters
·
Sep 08